Mutation or loss of Wilms' tumor gene 1 (WT1) are not major reasons for immune escape in patients with AML receiving WT1 peptide vaccination
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Mutation or loss of Wilms' tumor gene 1 (WT1) are not major reasons for immune escape in patients with AML receiving WT1 peptide vaccination ; volume:8 ; number:1 ; day:21 ; month:1 ; year:2010 ; pages:1-4 ; date:12.2010
Journal of translational medicine ; 8, Heft 1 (21.1.2010), 1-4, 12.2010
- Creator
-
Busse, Antonia
- Contributor
-
Letsch, Anne
Scheibenbogen, Carmen
Nonnenmacher, Anika
Ochsenreither, Sebastian
Thiel, Eckhard
Keilholz, Ulrich
SpringerLink (Online service)
- DOI
-
10.1186/1479-5876-8-5
- URN
-
urn:nbn:de:1111-2016041435353
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Busse, Antonia
- Letsch, Anne
- Scheibenbogen, Carmen
- Nonnenmacher, Anika
- Ochsenreither, Sebastian
- Thiel, Eckhard
- Keilholz, Ulrich
- SpringerLink (Online service)
Other Objects (12)
WT1 peptide analogue WT1-126Y enhances leukemia lysis
Treatment of three pediatric AML co-expressing NUP98-NSD1, FLT3-ITD, and WT1
Novel combined variants of WT1 and TET2 in a refractory and recurrent AML patient
Improvement of T-cell response against WT1-overexpressing leukemia by newly developed anti-hDEC205-WT1 antibody fusion proteins : = Verbesserung der T-Zellantwort gegen WT1-überexprimierende Leukämie mit neu entwickelten anti-hDEC205-WT1-Antikörperfusionsproteinen
Long term efficacy of WT1 peptide vaccine in patients with WT1 overexpressing hematopoeitic and solid malignancies
Analyse der spenderabhängigen WT1 spezifischen T-Zellexpansion
A role for Wt1 in female fertility
Der Transkriptionsfaktor Wt1 in Podozyten - eine genomweite ChlPseq Analyse der DNA Bindungsstellen von Wt1 in der Maus
Improvement of T-cell response against WT1-overexpressing leukemia by newly developed anti-hDEC205-WT1 antibody fusion proteins
Expressionsanalyse von WT1 in Hirntumoren : eine retrospektive Studie
Analyse WT1-regulierter Genexpression in stabil transfizierten Zellinien
Aufklärung molekularer Pathomechanismen des WT1-assoziierten nephrotischen Syndroms
WT1 peptide analogue WT1-126Y enhances leukemia lysis
Treatment of three pediatric AML co-expressing NUP98-NSD1, FLT3-ITD, and WT1
Novel combined variants of WT1 and TET2 in a refractory and recurrent AML patient
Improvement of T-cell response against WT1-overexpressing leukemia by newly developed anti-hDEC205-WT1 antibody fusion proteins : = Verbesserung der T-Zellantwort gegen WT1-überexprimierende Leukämie mit neu entwickelten anti-hDEC205-WT1-Antikörperfusionsproteinen
Long term efficacy of WT1 peptide vaccine in patients with WT1 overexpressing hematopoeitic and solid malignancies
Analyse der spenderabhängigen WT1 spezifischen T-Zellexpansion
A role for Wt1 in female fertility
Der Transkriptionsfaktor Wt1 in Podozyten - eine genomweite ChlPseq Analyse der DNA Bindungsstellen von Wt1 in der Maus
Improvement of T-cell response against WT1-overexpressing leukemia by newly developed anti-hDEC205-WT1 antibody fusion proteins
Expressionsanalyse von WT1 in Hirntumoren : eine retrospektive Studie
Analyse WT1-regulierter Genexpression in stabil transfizierten Zellinien
Aufklärung molekularer Pathomechanismen des WT1-assoziierten nephrotischen Syndroms
WT1 peptide analogue WT1-126Y enhances leukemia lysis
Treatment of three pediatric AML co-expressing NUP98-NSD1, FLT3-ITD, and WT1
Novel combined variants of WT1 and TET2 in a refractory and recurrent AML patient
Improvement of T-cell response against WT1-overexpressing leukemia by newly developed anti-hDEC205-WT1 antibody fusion proteins : = Verbesserung der T-Zellantwort gegen WT1-überexprimierende Leukämie mit neu entwickelten anti-hDEC205-WT1-Antikörperfusionsproteinen
Long term efficacy of WT1 peptide vaccine in patients with WT1 overexpressing hematopoeitic and solid malignancies
Analyse der spenderabhängigen WT1 spezifischen T-Zellexpansion
A role for Wt1 in female fertility
Der Transkriptionsfaktor Wt1 in Podozyten - eine genomweite ChlPseq Analyse der DNA Bindungsstellen von Wt1 in der Maus
Improvement of T-cell response against WT1-overexpressing leukemia by newly developed anti-hDEC205-WT1 antibody fusion proteins
Expressionsanalyse von WT1 in Hirntumoren : eine retrospektive Studie
Analyse WT1-regulierter Genexpression in stabil transfizierten Zellinien